:py:mod:`spark_auto_mapper_fhir.value_sets.research_study_phase`
================================================================

.. py:module:: spark_auto_mapper_fhir.value_sets.research_study_phase


Module Contents
---------------

Classes
~~~~~~~

.. autoapisummary::

   spark_auto_mapper_fhir.value_sets.research_study_phase.ResearchStudyPhaseCode
   spark_auto_mapper_fhir.value_sets.research_study_phase.ResearchStudyPhaseCodeValues




.. py:class:: ResearchStudyPhaseCode(value)

   Bases: :py:obj:`spark_auto_mapper_fhir.value_sets.generic_type.GenericTypeCode`

   ResearchStudyPhase
   From: http://terminology.hl7.org/CodeSystem/research-study-phase in valuesets.xml
       Codes for the stage in the progression of a therapy from initial experimental
   use in humans in clinical trials to post-market evaluation.

   .. py:attribute:: codeset
      :annotation: :spark_auto_mapper_fhir.fhir_types.uri.FhirUri = http://terminology.hl7.org/CodeSystem/research-study-phase

      


.. py:class:: ResearchStudyPhaseCodeValues

   Trials without phases (for example, studies of devices or behavioral
   interventions).
   From: http://terminology.hl7.org/CodeSystem/research-study-phase in valuesets.xml

   .. py:attribute:: N_A
      

      Designation for optional exploratory trials conducted in accordance with the
      United States Food and Drug Administration's (FDA) 2006 Guidance on
      Exploratory Investigational New Drug (IND) Studies. Formerly called Phase 0.
      From: http://terminology.hl7.org/CodeSystem/research-study-phase in valuesets.xml


   .. py:attribute:: EarlyPhase1
      

      Includes initial studies to determine the metabolism and pharmacologic actions
      of drugs in humans, the side effects associated with increasing doses, and to
      gain early evidence of effectiveness; may include healthy participants and/or
      patients.
      From: http://terminology.hl7.org/CodeSystem/research-study-phase in valuesets.xml


   .. py:attribute:: Phase1
      

      Trials that are a combination of phases 1 and 2.
      From: http://terminology.hl7.org/CodeSystem/research-study-phase in valuesets.xml


   .. py:attribute:: Phase1_Phase2
      

      Includes controlled clinical studies conducted to evaluate the effectiveness
      of the drug for a particular indication or indications in participants with
      the disease or condition under study and to determine the common short-term
      side effects and risks.
      From: http://terminology.hl7.org/CodeSystem/research-study-phase in valuesets.xml


   .. py:attribute:: Phase2
      

      Trials that are a combination of phases 2 and 3.
      From: http://terminology.hl7.org/CodeSystem/research-study-phase in valuesets.xml


   .. py:attribute:: Phase2_Phase3
      

      Includes trials conducted after preliminary evidence suggesting effectiveness
      of the drug has been obtained, and are intended to gather additional
      information to evaluate the overall benefit-risk relationship of the drug.
      From: http://terminology.hl7.org/CodeSystem/research-study-phase in valuesets.xml


   .. py:attribute:: Phase3
      

      Studies of FDA-approved drugs to delineate additional information including
      the drug's risks, benefits, and optimal use.
      From: http://terminology.hl7.org/CodeSystem/research-study-phase in valuesets.xml


   .. py:attribute:: Phase4